Literature DB >> 24722817

Hypothermia attenuates NO production in anesthetized rats with endotoxemia.

T S Hakim1, A Pedoto, J Nandi, G Bosco, A Rubini, D Mangar, A Paoli, E M Camporesi.   

Abstract

Sepsis is often associated with upregulation of nitric oxide production and fever, and it is common to control an excessive febrile response with antipyretic therapy and external cooling. Our aim was to evaluate the effect of hypothermia on NO production in a model of septic shock. Rats were anesthetized, ventilated, and instrumented for hemodynamic monitoring and divided into four groups. Normothermic controls (NC) received saline intravenously and were maintained at 37 °C. Hypothermic controls (HC) received saline but were allowed to become hypothermic. Normothermic endotoxic (NE) received Escherichia Coli lipopolysaccharides (LPS) intravenously to induce endotoxic shock and was maintained at 37 °C. Hypothermic endotoxic (HE) received LPS intravenously and was allowed to become hypothermic. Exhaled NO (NOe) was measured from mixed expired gas at time zero and every 30 min, for 5 h. After injection of LPS, NOe increased substantially in the NE group (700 ± 24 ppb), but increased only to 25 ± 2 ppb in the HE group. NOe increased to 90 ± 3 ppb in the NC group, and to 17.6 ± 3.1 ppb in the HC group after 5 h (P < 0.05), whilst blood pressure remained stable. In the HE group, blood pressure fell immediately after injection of the LPS, but thereafter remained stable despite the rise in NOe. In the NE group, the blood pressure fell gradually, and the animals became hypotensive. During the natural course of endotoxemia in anesthetized rats, allowing severe hypothermia to ensue by not actively managing temperature and hemodynamics resulted in significantly reduced expired NO concentrations, lung injury, and prolonged survival. The clinical benefits of such a finding currently remain unclear and merit further investigation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24722817     DOI: 10.1007/s00210-014-0977-1

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  42 in total

1.  HYPOTHERMIA IN BACTEREMIC SHOCK.

Authors:  E BLAIR; G HENNING; R HORNICK; R A COWLEY
Journal:  Arch Surg       Date:  1964-10

2.  The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study.

Authors:  Carl I Schulman; Nicholas Namias; James Doherty; Ronald J Manning; Pamela Li; Pam Li; Ahmed Elhaddad; Ahmed Alhaddad; David Lasko; Jose Amortegui; Christopher J Dy; Lucie Dlugasch; Gio Baracco; Stephen M Cohn
Journal:  Surg Infect (Larchmt)       Date:  2005       Impact factor: 2.150

Review 3.  Use of nitric oxide synthase inhibitors as a novel treatment for septic shock.

Authors:  T A Wolfe; J F Dasta
Journal:  Ann Pharmacother       Date:  1995-01       Impact factor: 3.154

4.  Effects of nitric oxide synthase inhibitors on systemic hypotension, cytokines and inducible nitric oxide synthase expression and lung injury following endotoxin administration in rats.

Authors:  D Wang; J Wei; K Hsu; J Jau; M W Lieu; T J Chao; H I Chen
Journal:  J Biomed Sci       Date:  1999-01       Impact factor: 8.410

5.  Effects of nitric oxide inhibition on thermoregulation during exercise in the horse.

Authors:  P C Mills; C M Scott; D J Marlin
Journal:  Ann N Y Acad Sci       Date:  1997-03-15       Impact factor: 5.691

6.  Induced hypothermia for sepsis?

Authors:  A Gilston
Journal:  Crit Care Med       Date:  1993-08       Impact factor: 7.598

7.  Fever control in septic shock: beneficial or harmful?

Authors:  Fuhong Su; Nam Duc Nguyen; Zhen Wang; Ying Cai; Peter Rogiers; Jean-Louis Vincent
Journal:  Shock       Date:  2005-06       Impact factor: 3.454

8.  A role for nitric oxide in active thermoregulatory vasodilation.

Authors:  W F Taylor; V S Bishop
Journal:  Am J Physiol       Date:  1993-05

9.  Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group.

Authors:  T P Clemmer; C J Fisher; R C Bone; G J Slotman; C A Metz; F O Thomas
Journal:  Crit Care Med       Date:  1992-10       Impact factor: 7.598

10.  Nitric oxide is not permissive for cutaneous active vasodilatation in humans.

Authors:  Brad W Wilkins; Lacy A Holowatz; Brett J Wong; Christopher T Minson
Journal:  J Physiol       Date:  2003-03-21       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.